N-{3-[4-(2-Pyridineimidoylamino-propyl)-piperazin-1-yl]-propyl}-pyridine-2-carboxamidine

ID: ALA2316052

PubChem CID: 71569073

Max Phase: Preclinical

Molecular Formula: C22H32N8

Molecular Weight: 408.55

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(NCCCN1CCN(CCCNC(=N)c2ccccn2)CC1)c1ccccn1

Standard InChI:  InChI=1S/C22H32N8/c23-21(19-7-1-3-9-25-19)27-11-5-13-29-15-17-30(18-16-29)14-6-12-28-22(24)20-8-2-4-10-26-20/h1-4,7-10H,5-6,11-18H2,(H2,23,27)(H2,24,28)

Standard InChI Key:  NDKJXDNCAVZVKY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 32  0  0  0  0  0  0  0  0999 V2000
   39.4053  -15.6203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6956  -16.0300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9880  -15.6203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9889  -14.8010    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.7033  -14.3931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4080  -14.8052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7076  -13.5759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0020  -13.1637    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.4174  -13.1710    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.2922  -13.5686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5866  -13.1563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8025  -11.1352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8014  -11.9548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5094  -12.3637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2191  -11.9543    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.2162  -11.1316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5076  -10.7264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9224  -10.7204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6317  -11.1263    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.9193   -9.9032    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.6347  -11.9435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3440  -12.3494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0501  -11.9381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7594  -12.3441    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.7575  -13.1582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4626  -13.5641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1712  -13.1563    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.1701  -12.3381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4604  -11.9278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8789  -13.5649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  7  9  2  0
  8 10  1  0
 10 11  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 16 18  1  0
 18 19  1  0
 18 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 27 30  1  0
 30 11  1  0
M  END

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PA-1 (704 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-15 (51914 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H522 (44358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T47D (39041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

COS-1 (266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 408.55Molecular Weight (Monoisotopic): 408.2750AlogP: 1.40#Rotatable Bonds: 10
Polar Surface Area: 104.02Molecular Species: BASEHBA: 6HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.01CX LogP: 0.49CX LogD: -2.68
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.27Np Likeness Score: -0.82

References

1. Arya S, Kumar N, Roy P, Sondhi SM..  (2013)  Synthesis of amidine and bis amidine derivatives and their evaluation for anti-inflammatory and anticancer activity.,  59  [PMID:23202484] [10.1016/j.ejmech.2012.10.046]

Source